Oasis Diagnostics

  • Oasis Diagnostics has developed a platform for efficient collection of high-quality salivary specimens; proprietary polyalkene-based absorbent material offers advantage over competing paper-based solutions
  • Company pursuing applications in multiple screening and diagnostics ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Cardea Bio

Company Profile | December 13, 2020

Offers graphene‑based lab‑on‑a‑chip biosensor systems, including biology‑gated graphene field‑effect transistors that allow for electronic chipsets built with molecular biology (e.g., integrating clustered regularly interspaced short palindromic repeats [CRISPR]), electronic devices, AI and ... To read more, click here.

SnapDNA

Company Profile | May 13, 2022

​​​​​Develops a rapid pathogen detection platform,TrueRapid; the system works by selectively capturing only live pathogenic bacteria cells by binding to aptamers Claims the system is capable of delivering quantitative analysis for the presence of food pathogens in 20 minutes and reducing the ... Not part of subscription

ChipCare

Company Profile | March 23, 2022

ChipCare develops microfluidics‑based, handheld cell analyzers for cell, protein, and pathogen detection Competitive differentiation from portability, multiplexing, and lack of need for refrigeration, accomplished via their proprietary reagent drying process First‑generation platform screens ... Not part of subscription